Haemolytic disease of the newborn
- PMID: 17337672
- PMCID: PMC2675453
- DOI: 10.1136/adc.2005.076794
Haemolytic disease of the newborn
Abstract
The changing management of haemolytic disease of the newborn is reviewed
Conflict of interest statement
Competing interests: None.
References
-
- Wang m, Hays T, Ambruso DR, et al Hemolytic disease of the newborn caused by a high titer anti‐group B IgG from a group A mother. Pediatr Blood Cancer 200545861–862. - PubMed
-
- Chen J Y, Ling U P. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility. Zhonghua Yi Xue Za Zhi (Taipei) 19945313–18. - PubMed
-
- Oski F A. The erythrocyte and its disorders. In: Nathan A, Oski FA, eds. Hematology of infancy and childhood. Philadelphia: WB Saunders, 199318–43.
-
- Waldron P, de Alarcon P. ABO hemolytic disease of the newborn: a unique constellation of findings in siblings and review of protective mechanisms in the fetal‐maternal system. Am J Perinatol 199916391–398. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources